| Lung Cancer |
| Disease Name: |
Non-Small Cell Lung Cancer, Esophageal cancer |
| Title of trial: |
A pilot study of NY-ESO-1b peptide plus CpG 7909 and MontanideTM ISA-51 in patients with cancer expressing NY-ESO-1 or LAGE-1 |
| Contact person: |
Dr. Altorki [Cathy Ferrara, RN (212) 746-3328] |
 |
| Disease name: |
Non-small Cell Lung Cancer |
| Title of trial: |
Safety and immunological evaluation of NY-ESO-1 Plasmid DNA (pPJV7611) Cancer Vaccine given by particle-mediated epidermal delivery (PMED) in patients with NY-ESO-1 or LAGE-1 expressing non-small cell lung cancer |
| Contact person: |
Dr. Altorki [Cathy Ferrara, RN (212) 746-3328] |
|
| Disease Name: |
Non-small Cell Lung Cancer |
| Title of trial: |
Safety and immunological evaluation of NY-ESO-1 Plasmid DNA (pPJV7611) Cancer Vaccine given by particle-mediated epidermal delivery (PMED) in patients with NY-ESO-1 or LAGE-1 expressing non-small cell lung cancer |
| Contact person: |
Dr. Altorki [Cathy Ferrara, RN (212) 746-3328] |
|
| Disease Name: |
Non-small Cell Lung Cancer |
| Title of trial: |
A phase II trial of induction chemoradiotherapy with cisplatin/etoposide followed by surgical resection, followed by docetaxel for non-small cell lung cancer involving the superior sulcus (Pancoast tumors) |
| Contact person: |
Dr. Altorki [Cathy Ferrara, RN (212) 746-3328] |
| |
| Esophageal Cancer |
| Disease Name: |
Non-Small Cell Lung Cancer, Esophageal cancer, Other cancers |
| Title of trial: |
A pilot study of NY-ESO-1b peptide plus CpG 7909 and MontanideTM ISA-51 in patients with cancer expressing NY-ESO-1 or LAGE-1 |
| Contact person: |
Dr. Altorki [Cathy Ferrara, RN (212) 746-3328] |
| |
|
| Disease Name: |
Esophageal Cancer |
| Title of trial: |
A Phase II Study of Preoperative Celecoxib/Paclitaxel/Carboplatin for Squamous Cell and Adenocarcinoma of the Esophagus |
| Contact person: |
Dr. Altorki [Cathy Ferrara, RN (212) 746-3328] |
| |
|
| Disease Name: |
Non-Small Cell Lung Cancer, Esophageal cancer, Other cancers |
| Title of trial: |
A pilot study of NY-ESO-1b peptide plus CpG 7909 and MontanideTM ISA-51 in patients with cancer expressing NY-ESO-1 or LAGE-1 |
| Contact person: |
Dr. Altorki [Cathy Ferrara, RN (212) 746-3328] |
| |
|
| Non-treatment (Correlative/Screening) Studies |
Disease name: |
Lung and esophageal abnormalities |
| Title of trial: |
Correlative studies on angiogenesis and lymphangiogenesis in lung and esophageal abnormalities |
| Contact person: |
Dr. Altorki [Cathy Ferrara, RN (212) 746-3328] |
| |
|
| Disease name: |
Non-Small Cell Lung Cancer, Esophageal cancer, Other cancers |
| Title of trial: |
Evaluation of tumor antigen expression and specific immune responses in cancer patients |
| Contact person: |
Dr. Altorki [Cathy Ferrara, RN (212) 746-3328] |
|
|
Contact
